Tonsil-derived mesenchymal stem cells exert immunosuppressive effects on T cells

Area of Science:

• Immunology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) possess immunomodulatory properties.
• Tonsils are a readily accessible source of MSCs in children.
• Understanding MSC immunomodulation is crucial for therapeutic applications.

Purpose of the Study:

• To evaluate the immunomodulatory effects of tonsil-derived MSCs.
• To assess the impact of MSCs on T-lymphocyte proliferation.
• To determine the influence of MSCs on T helper 1 (Th1) and T helper 2 (Th2) cytokine production.

Main Methods:

• Tonsils were collected from pediatric patients undergoing tonsillectomy.
• Tonsil-derived MSCs were co-cultured with peripheral blood mononuclear cells (PBMCs).
• PBMCs were stimulated with phytohemagglutinin (PHA) to induce proliferation and differentiation into Th1 or Th2 cells.

Main Results:

• Tonsil-derived MSCs significantly suppressed PHA-induced PBMC proliferation.
• Co-culture with MSCs led to a significant decrease in interferon-gamma (IFN-γ) production (Th1 cytokine).
• Co-culture with MSCs resulted in a significant increase in interleukin-4 (IL-4) production (Th2 cytokine).

Conclusions:

• Tonsil-derived MSCs exhibit potent immunomodulatory capabilities.
• These MSCs effectively suppress T-lymphocyte proliferation.
• Tonsil-derived MSCs promote a shift in T-cell cytokine profiles, favoring Th2 over Th1 responses.